Sanofi (SNY) Gross Margin (2009 - 2026)
Sanofi's Gross Margin was 79.32% in Q3 2026, up 0.84 percentage points from 78.48% a year earlier but down 0.73 percentage points from the prior quarter.
Sanofi (SNY) Gross Margin (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Sanofi's Gross Margin was 115.40% through Sep 30, 2026, up 65.67 percentage points year-over-year; for FY2025, it came in at 77.17%, up 1.51 percentage points from FY2024.
- Gross Margin shows a five-year change of +7.22 percentage points (FY2020 to FY2025).
- In earlier years, Gross Margin was 75.66% in FY2024 (-1.00 pp), 76.66% in FY2023 (+0.49 pp), 76.17% in FY2022 (+4.88 pp) and 71.29% in FY2021 (+1.34 pp).
- Quarterly Gross Margin has moved between 23.96% (Q2 2025) and 87.10% (Q4 2023) over five years.
- Compared with a year earlier, Gross Margin was higher in four of the last seven quarters, with an average year-over-year change of +0.63 percentage points.
- The best year-over-year quarter for Gross Margin over five years was Q2 2026 (a gain of 56.09 percentage points); the worst was Q2 2025 (a drop of 52.06 percentage points).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,289.41 Bn | 1,263.02 Bn | 20.46 Bn | 83.88% |
| 2 | Johnson & Johnson | 687.33 Bn | 607.19 Bn | 17.30 Bn | 68.12% |
| 3 | AbbVie | 524.88 Bn | 492.89 Bn | 13.12 Bn | 75.38% |
| 4 | Merck | 361.94 Bn | 324.89 Bn | 13.19 Bn | 72.95% |
| 5 | Novartis Ag | 313.59 Bn | 286.83 Bn | - | - |
| 6 | Astrazeneca | 287.15 Bn | 260.67 Bn | 13.26 Bn | 88.03% |
| 7 | Amgen | 253.53 Bn | 205.18 Bn | 7.58 Bn | 73.10% |
| 8 | Gilead Sciences | 210.46 Bn | 185.57 Bn | 6.73 Bn | 81.07% |
| 9 | Pfizer | 165.39 Bn | 112.74 Bn | 12.56 Bn | 75.71% |
| 10 | Sanofi | 59.45 Bn | 29.65 Bn | 33.35 Bn | 79.32% |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 79.32% |
| Jun 30, 2026 | 80.05% |
| Mar 31, 2026 | 77.13% |
| Sep 30, 2025 | 78.48% |
| Jun 30, 2025 | 23.96% |
| Mar 31, 2025 | 77.99% |
| Dec 31, 2024 | 83.31% |
| Sep 30, 2024 | 76.61% |
| Jun 30, 2024 | 76.02% |
| Mar 31, 2024 | 75.64% |
| Dec 31, 2023 | 87.10% |
| Sep 30, 2023 | 74.03% |
| Jun 30, 2023 | 74.40% |
| Mar 31, 2023 | 76.15% |
| Dec 31, 2022 | 72.00% |
| Sep 30, 2022 | 74.56% |
| Jun 30, 2022 | 74.06% |
| Mar 31, 2022 | 74.15% |
| Dec 31, 2021 | 69.44% |
| Sep 30, 2021 | 72.76% |
Sanofi Gross Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=gross-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "gross-margin", "ticker": "SNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=gross-margin&ticker=SNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();